Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.952 EUR | +2.74% | -1.42% | -60.93% |
05-03 | Crossject: praised for extended agreement on Zepizure | CF |
05-02 | Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe | CI |
Official Publications
- Stock Market
- Equities
- ALCJ Stock
- News Crossject
- Official Publications